Table 1.
Compound | % variation | p-value | VIP |
---|---|---|---|
Ramsey Fe+ vs. Ramsey Fe−; 3 h | |||
Increased abundance | |||
l-glutamate | 16,160.03 | 0.004 | 2.19 |
Cyclolariciresinol | 8.19 | 0.0393 | 1.74 |
Caprylic acid | 61.19 | 0.0498 | 1.71 |
Decreased abundance | |||
Campesteryl ferulate | 19.36 | 0.0169 | 2 |
140R Fe+ vs. 140R Fe−; 3 h | |||
Increased abundance | |||
3-Sinapoylquinic acid | 6.25 | 0.0016 | 1.85 |
p-Coumaric acid-4-O-glucoside | 5.07 | 0.0022 | 1.80 |
Apigenin 6-C-glucoside | 5.57 | 0.0042 | 1.75 |
2-Methoxy-5-prop-1-enylphenol | 18.17 | 0.0086 | 1.66 |
Cyclolariciresinol | 9.94 | 0.0074 | 1.65 |
Avenanthramide 2f. | 5.79 | 0.0114 | 1.64 |
1-Acetoxypinoresinol | 5.56 | 0.0111 | 1.62 |
Isoxanthohumol | 5.31 | 0.0194 | 1.53 |
5-Heneicosenylresorcinol | 9.74 | 0.0256 | 1.49 |
Caffeic acid ethyl ester | 10.29 | 0.026 | 1.48 |
Benzoxazinone | 7.63 | 0.0273 | 1.47 |
l-histidine | 11.16 | 0.0458 | 1.40 |
l-ascorbate | 54.86 | 0.04 | 1.38 |
Gallic acid ethyl ester | 6.14 | 0.0492 | 1.33 |
Decreased abundance | |||
Campesteryl ferulate | 45.32 | 0.0408 | 1.42 |
Schottenol ferulate | 13.52 | 0.0381 | 1.41 |
Ramsey Fe+ vs. Ramsey Fe−; 6 h | |||
Increased abundance | |||
l-glutamate | 63,740.98 | < 0.0001 | 2.50 |
Maltose/sucrose | 216.50 | 0.0043 | 2.00 |
l-tyrosine | 242.13 | 0.0074 | 1.98 |
Homoveratric acid | 52.02 | 0.0209 | 1.76 |
Decreased abundance | |||
Sakuranetin | 60.09 | 0.0352 | 1.71 |
4-Hydroxycoumarin | 6.93 | 0.0462 | 1.66 |
140R Fe+ vs. 140R Fe−; 6 h | |||
Increased abundance | |||
l-glutamate | 25,186.35 | < 0.0001 | 2.17 |
Caffeic acid 4-O-glucoside | 82.92 | 0.0049 | 1.79 |
Maltose/sucrose | 98.31 | 0.0047 | 1.77 |
Wighteone | 15.30 | 0.0073 | 1.74 |
Episesamin | 15.30 | 0.0073 | 1.74 |
3,4 Dihydroxyphenyl-2-oxypropanoic acid | 35.43 | 0.0101 | 1.69 |
2-Methoxy-5-prop-1-enylphenol | 8.36 | 0.0165 | 1.60 |
2-Hydroxybenzoic acid | 5.37 | 0.0253 | 1.52 |
l-methionine | 67.82 | 0.0429 | 1.46 |
Decreased abundance | |||
Campesteryl ferulate | 11.19 | 0.0302 | 1.55 |
The percentage increase or decrease, p-value for t-test and VIP value from OPLS-DA are reported for each compound.